Efficient decontamination of zearalenone, the mycotoxin of cereal pathogen, by transgenic yeasts through the expression of a synthetic lactonohydrolase gene
- 4 January 2005
- journal article
- applied microbial-and-cell-physiology
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 67 (6) , 838-844
Abstract
Zearalenone (ZEN), an estrogenic mycotoxin produced by several Fusarium species, is converted to a non-estrogenic product by a detoxifying enzyme of Clonostachys rosea. Previously, we investigated whether recombinant Saccharomyces cerevisiae carrying this detoxification gene, zhd101, can remove 2 μg ml−1 of ZEN in a liquid culture. Although the transgenic yeasts eliminated most of the ZEN, they also converted a significant amount to a poor substrate, β-zearalenol, which remained in the medium. In this study, we synthesized a codon-optimized zhd101 gene and investigated whether the transgenic yeast strain can overcome the problem of insufficient detoxification of ZEN. Importantly, within 48 h of incubation at 28°C or 8 h of incubation at 37°C, the transgenic yeasts completely eliminated 2 μg ml−1 of ZEN in the medium without accumulating even a trace amount of β-zearalenol. The result suggests that incomplete ZEN detoxification attributed to the action of an endogenous yeast β-reductase can be overcome by simply increasing the expression of the detoxifying gene.Keywords
This publication has 23 references indexed in Scilit:
- Living recombinant Saccharomyces cerevisiae secreting proteins or peptides as a new drug delivery system in the gutJournal of Biotechnology, 2004
- RecombinantSaccharomyces cerevisiaeExpressing P450 in Artificial Digestive Systems: a Model for Biodetoxication in the Human Digestive EnvironmentApplied and Environmental Microbiology, 2003
- A novel lactonohydrolase responsible for the detoxification of zearalenone: enzyme purification and gene cloningBiochemical Journal, 2002
- Biotransformation of the Mycotoxin, Zearalenone, to a Non-estrogenic Compound by a Fungal Strain ofClonostachyssp.Bioscience, Biotechnology, and Biochemistry, 2002
- The ‘biodrug’ concept: an innovative approach to therapyTrends in Biotechnology, 2001
- ASSESSMENT OF THE ESTROGENIC EFFECTS OF ZEARALENONE AFTER TREATMENT WITH OZONE UTILIZING THE MOUSE UTERINE WEIGHT BIOASSAYJournal of Toxicology and Environmental Health, Part A, 1999
- Metabolism of the Fusarium mycotoxins zearalenone and deoxynivalenol by yeast strains of technological relevanceNatural Toxins, 1995
- Cloning of the blasticidin S deaminase gene (BSD) from Aspergillus terreus and its use as a selectable marker for Schizosaccharomyces pombe and Pyricularia oryzaeMolecular Genetics and Genomics, 1994
- PRECOCIOUS SEXUAL DEVELOPMENT IN PUERTO RICO AND OESTROGENIC MYCOTOXINS (ZEARALENONE)The Lancet, 1983
- Effects of Zearalenone (F2) on Estrous Activity and Reproduction in Gilts2Journal of Animal Science, 1982